Načítá se...
Timing of Transjugular Intrahepatic Portosystemic Shunt for Budd-Chiari Syndrome: An Italian Hepatologist’s Perspective
Budd-Chiari syndrome (BCS) management flow-chart is derived from experts’ opinion and is not evidence-based. Guidelines suggest BCS management should follow a stepwise strategy: medical therapy as first-line treatment, revascularization or transjugular intrahepatic portosystemic shunt (TIPS) if no r...
Uloženo v:
| Vydáno v: | J Transl Int Med |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
De Gruyter Open
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5767708/ https://ncbi.nlm.nih.gov/pubmed/29340275 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1515/jtim-2017-0033 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|